Tag: models

RANCHO CUCAMONGA, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) ("iPower" or the "Company"), a tech and data-driven eCommerce service provider and online retailer, today announced a strategic partnership with Borg Rise U.S., a dynamic and fast-growing player in digital content and social media commerce. This partnership marks a key milestone in iPower’s strategy to expand its omnichannel presence through influencer-driven and content-based sales models across platforms like TikTok, Instagram, and YouTube.

Tuebingen, Germany, June 10, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced that the first patient has been dosed in their Phase Ib clinical trial of its lead candidate HRX-215. The trial is evaluating the safety and efficacy of HRX-215, an orally available small-molecule inhibitor of MKK4, in patients undergoing partial liver resection due to liver metastases deriving from colorectal cancer. HXR-215 is designed to treat advanced-stage liver disease by increasing the regenerative capacity of hepatocytes. An initial data readout is planned for the second half of 2025.

The Europe spinal navigation market, valued at $192.1 million in 2023, is projected to reach $754.7 million by 2032, growing at a CAGR of 16.42%. Advanced technologies enhance spine surgery accuracy, patient safety, and outcomes despite high investment costs. Overcoming financial and regulatory hurdles is key for widespread adoption.